首页 > 最新文献

Vascular disease prevention最新文献

英文 中文
Fenoldopam in cardiovascular surgery: A review 非诺多泮在心血管手术中的应用综述
Pub Date : 2008-11-01 DOI: 10.2174/1567270000805010029
G. Landoni, Francesco Alfredo Garozzo, A. Mizzi, A. Zangrillo
{"title":"Fenoldopam in cardiovascular surgery: A review","authors":"G. Landoni, Francesco Alfredo Garozzo, A. Mizzi, A. Zangrillo","doi":"10.2174/1567270000805010029","DOIUrl":"https://doi.org/10.2174/1567270000805010029","url":null,"abstract":"","PeriodicalId":88793,"journal":{"name":"Vascular disease prevention","volume":"5 1","pages":"223-226"},"PeriodicalIF":0.0,"publicationDate":"2008-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67887997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circadian Variation of Cardiovascular Events and Morning Blood Pressure Surge 心血管事件的昼夜变化和清晨血压激增
Pub Date : 2008-11-01 DOI: 10.2174/1567270000805010032
R. Manfredini, B. Boari, R. Salmi, M. Gallerani, M. Felisatti, S. Mandini, A. Malagoni, F. Manfredini
{"title":"Circadian Variation of Cardiovascular Events and Morning Blood Pressure Surge","authors":"R. Manfredini, B. Boari, R. Salmi, M. Gallerani, M. Felisatti, S. Mandini, A. Malagoni, F. Manfredini","doi":"10.2174/1567270000805010032","DOIUrl":"https://doi.org/10.2174/1567270000805010032","url":null,"abstract":"","PeriodicalId":88793,"journal":{"name":"Vascular disease prevention","volume":"5 1","pages":"246-251"},"PeriodicalIF":0.0,"publicationDate":"2008-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67888009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Edema, Inflammation and Fibrosis - Comparison Between Catecholamine- and Hypoxia-Induced Pulmonary Injuries 水肿、炎症和纤维化——儿茶酚胺和缺氧所致肺损伤的比较
Pub Date : 2008-11-01 DOI: 10.2174/1567270000805010027
B. Rassler
{"title":"Edema, Inflammation and Fibrosis - Comparison Between Catecholamine- and Hypoxia-Induced Pulmonary Injuries","authors":"B. Rassler","doi":"10.2174/1567270000805010027","DOIUrl":"https://doi.org/10.2174/1567270000805010027","url":null,"abstract":"","PeriodicalId":88793,"journal":{"name":"Vascular disease prevention","volume":"25 1","pages":"211-218"},"PeriodicalIF":0.0,"publicationDate":"2008-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67888149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Ultrasound Vascular Imaging in the Acute Phase of Stroke 超声血管成像在脑卒中急性期的作用
Pub Date : 2008-11-01 DOI: 10.2174/1567270000805010033
G. Malferrari, M. Zedde, N. Marcello
{"title":"Role of Ultrasound Vascular Imaging in the Acute Phase of Stroke","authors":"G. Malferrari, M. Zedde, N. Marcello","doi":"10.2174/1567270000805010033","DOIUrl":"https://doi.org/10.2174/1567270000805010033","url":null,"abstract":"","PeriodicalId":88793,"journal":{"name":"Vascular disease prevention","volume":"5 1","pages":"252-269"},"PeriodicalIF":0.0,"publicationDate":"2008-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67888943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The Trigeminocardiac Reflex as Oxygen Conserving Reflex in Humans: Its Ischemic Tolerance Potential 三叉心反射作为人的保氧反射:其缺血耐受电位
Pub Date : 2008-10-31 DOI: 10.2174/1567270000805010028
B. Schaller, K. Prank
{"title":"The Trigeminocardiac Reflex as Oxygen Conserving Reflex in Humans: Its Ischemic Tolerance Potential","authors":"B. Schaller, K. Prank","doi":"10.2174/1567270000805010028","DOIUrl":"https://doi.org/10.2174/1567270000805010028","url":null,"abstract":"","PeriodicalId":88793,"journal":{"name":"Vascular disease prevention","volume":"5 1","pages":"219-222"},"PeriodicalIF":0.0,"publicationDate":"2008-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67887988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Viewing the Cardiovascular Pathogenicity of Lp(a) from the Pro-Inflammatory Side 从促炎角度观察Lp(a)的心血管致病性
Pub Date : 2008-08-01 DOI: 10.2174/1567270000805010019
Binu B. Philips, A. Scanu
{"title":"Viewing the Cardiovascular Pathogenicity of Lp(a) from the Pro-Inflammatory Side","authors":"Binu B. Philips, A. Scanu","doi":"10.2174/1567270000805010019","DOIUrl":"https://doi.org/10.2174/1567270000805010019","url":null,"abstract":"","PeriodicalId":88793,"journal":{"name":"Vascular disease prevention","volume":"5 1","pages":"150-155"},"PeriodicalIF":0.0,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67887883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
C-Reactive Protein and Atherosclerosis: An Update c反应蛋白与动脉粥样硬化:最新进展
Pub Date : 2008-08-01 DOI: 10.2174/1567270000805010023
J. Torzewski, V. Hombach, G. Nienhaus
{"title":"C-Reactive Protein and Atherosclerosis: An Update","authors":"J. Torzewski, V. Hombach, G. Nienhaus","doi":"10.2174/1567270000805010023","DOIUrl":"https://doi.org/10.2174/1567270000805010023","url":null,"abstract":"","PeriodicalId":88793,"journal":{"name":"Vascular disease prevention","volume":"5 1","pages":"178-182"},"PeriodicalIF":0.0,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67887950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Effect of Colestimide on Reduction of Body Weight and Waist Circumference in Metabolic Syndrome Patients with Cardiovascular Risk Factors Colestimide对合并心血管危险因素的代谢综合征患者体重和腰围的影响
Pub Date : 2008-08-01 DOI: 10.2174/1567270000805010024
M. Yamaoka-Tojo, T. Tojo, Rie Kosugi, N. Aoyama, S. Niwano, S. Kurokawa, T. Izumi
Background and objective: Insulin resistance is thought to be central to the pathogenesis of abdominal obesity- linked metabolic syndrome (MetS). Colestimide, a 2-methylimidazole-epichlorohydrin polymer, is a new bile-acid- sequestering resin used to lower LDL cholesterol. In recent reports, bile acid-controlled signaling pathways have shown promise as novel drug targets to treat metabolic disorders, such as obesity, type 2 diabetes, hyperlipidemia, and athero- sclerosis. The aim of this study was to evaluate the efficacy of colestimide on weight loss in MetS patients. Methods: Sixty-one patients with MetS who had cardiovascular risk factors were randomized to receive lifestyle counsel- ing with or without colestimide treatment. The primary endpoint was achieved when the reduction in body weight is � 5%. Additionally, differences in the waist circumference and metabolic-associated profiles between the colestimide group and the control group, which received lifestyle modifications alone, were analyzed. Results: The numbers of participants who achieved � 5% weight loss significantly favored the colestimide group over the non-colestimide group (71.4% vs. 33.3%; p < 0.01). The mean reduction in waist circumference during the study period (average 22 weeks) was greater with colestimide than without it (10.1 � 5.4 vs. 7.1 � 5.2 cm, p < 0.05). Conclusions: The colestimide treatment together with lifestyle intervention was associated with reduction in body weight and waist circumference over a relatively short term in obese subjects. The combination of colestimide and lifestyle inter- vention may be useful for weight management in MetS patients with cardiovascular risk factors.
背景和目的:胰岛素抵抗被认为是腹部肥胖相关代谢综合征(MetS)发病的核心。Colestimide是一种2-甲基咪唑-环氧氯丙烷聚合物,是一种用于降低低密度脂蛋白胆固醇的新型胆汁酸隔离树脂。在最近的报道中,胆汁酸控制的信号通路已经显示出作为治疗代谢性疾病(如肥胖、2型糖尿病、高脂血症和动脉粥样硬化)的新药物靶点的前景。本研究的目的是评估colestimide对MetS患者减肥的疗效。方法:61例有心血管危险因素的met患者被随机分为两组,分别接受有或没有colestimide治疗的生活方式咨询。当体重减少5%时达到主要终点。此外,还分析了colestimide组和对照组(仅接受生活方式改变)腰围和代谢相关曲线的差异。结果:达到5%体重减轻的参与者数量明显优于非colestimide组(71.4% vs 33.3%;P < 0.01)。在研究期间(平均22周),使用colestimide组的腰围平均减少量大于未使用colestimide组(10.1 - 5.4 cm vs. 7.1 - 5.2 cm, p < 0.05)。结论:在相对较短的时间内,colestimide治疗和生活方式干预与肥胖受试者体重和腰围的减少有关。colestimide联合生活方式干预可能对有心血管危险因素的MetS患者的体重管理有用。
{"title":"Effect of Colestimide on Reduction of Body Weight and Waist Circumference in Metabolic Syndrome Patients with Cardiovascular Risk Factors","authors":"M. Yamaoka-Tojo, T. Tojo, Rie Kosugi, N. Aoyama, S. Niwano, S. Kurokawa, T. Izumi","doi":"10.2174/1567270000805010024","DOIUrl":"https://doi.org/10.2174/1567270000805010024","url":null,"abstract":"Background and objective: Insulin resistance is thought to be central to the pathogenesis of abdominal obesity- linked metabolic syndrome (MetS). Colestimide, a 2-methylimidazole-epichlorohydrin polymer, is a new bile-acid- sequestering resin used to lower LDL cholesterol. In recent reports, bile acid-controlled signaling pathways have shown promise as novel drug targets to treat metabolic disorders, such as obesity, type 2 diabetes, hyperlipidemia, and athero- sclerosis. The aim of this study was to evaluate the efficacy of colestimide on weight loss in MetS patients. Methods: Sixty-one patients with MetS who had cardiovascular risk factors were randomized to receive lifestyle counsel- ing with or without colestimide treatment. The primary endpoint was achieved when the reduction in body weight is � 5%. Additionally, differences in the waist circumference and metabolic-associated profiles between the colestimide group and the control group, which received lifestyle modifications alone, were analyzed. Results: The numbers of participants who achieved � 5% weight loss significantly favored the colestimide group over the non-colestimide group (71.4% vs. 33.3%; p < 0.01). The mean reduction in waist circumference during the study period (average 22 weeks) was greater with colestimide than without it (10.1 � 5.4 vs. 7.1 � 5.2 cm, p < 0.05). Conclusions: The colestimide treatment together with lifestyle intervention was associated with reduction in body weight and waist circumference over a relatively short term in obese subjects. The combination of colestimide and lifestyle inter- vention may be useful for weight management in MetS patients with cardiovascular risk factors.","PeriodicalId":88793,"journal":{"name":"Vascular disease prevention","volume":"5 1","pages":"183-189"},"PeriodicalIF":0.0,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67887958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
C(6)-Ceramide-Coated Catheters Promote Re-Endothelialization of Stretch-Injured Arteries. C(6)-神经酰胺涂层导管促进拉伸损伤动脉的再内皮化。
Pub Date : 2008-08-01 DOI: 10.2174/156727008785133809
Sean M O'Neill, Dina K Olympia, Todd E Fox, J Tony Brown, Thomas C Stover, Kristy L Houck, Ronald Wilson, Peter Waybill, Mark Kozak, Steven W Levison, Norbert Weber, Linda M Karavodin, Mark Kester

OBJECTIVE: Drug eluting stents have recently been associated with the increased risk of adverse thrombogenic events and/or late luminal loss, which is highly associated with incomplete re-endothelialization. The increased risks behoove the design of alternative delivery modalities and/or drugs that do not compromise the re-endotheliaization process. The objective of the present study is to elucidate the biological mechanism(s) by which non-stent-based delivery modalities for the anti-proliferative lipid metabolite, C(6)-ceramide, could lead to a reduction in arterial injury after angioplasty. RESULTS: Immunohistochemical studies in rabbit and porcine models suggest that C(6)-ceramide-coated balloon catheters limit arterial stenosis without inhibiting endothelial wound healing responses. Specifically, C(6)-ceramide-coated balloon catheters reduce internal elastica injury with a corresponding reduction in medial fracture length in a 28-day porcine coronary artery stretch model. In addition, C(6)-ceramide decreases the formation of the fibrin matrix to possibly augment the subsequent wound healing response. We hypothesized that differential metabolism of exogenous ceramide by coronary endothelial and smooth muscle cells could explain the apparent discrepancy between the anti-proliferative actions of ceramide and the pro-wound healing responses of ceramide. Human coronary artery endothelial cells (HCAEC), in contrast to human coronary artery smooth muscle cells (HCASMC), preferentially express ceramide kinase and form ceramide-1-phosphate, which promotes endothelial cell survival. CONCLUSION: Differential metabolism of ceramide between HCASMC and HCAEC offers a mechanism by which ceramide preferentially limits smooth muscle cell growth, in the presence of active wound healing. The combinatorial ability of ceramide to limit vascular smooth muscle proliferation and promote re-endothelialization, offers the potential for C(6)-ceramide-coated catheters to serve as adjuncts to stent-based modalities or as a stand-alone treatment.

目的:药物洗脱支架最近与不良血栓形成事件和/或晚期腔内损失的风险增加相关,这与不完全再内皮化高度相关。增加的风险需要设计不危及再内皮化过程的替代给药方式和/或药物。本研究的目的是阐明抗增生性脂质代谢物C(6)-神经酰胺的非支架递送方式可能导致血管成形术后动脉损伤减少的生物学机制。结果:兔和猪模型的免疫组织化学研究表明,C(6)-神经酰胺包被球囊导管限制动脉狭窄,而不抑制内皮伤口愈合反应。具体来说,在28天的猪冠状动脉拉伸模型中,C(6)-神经酰胺涂层球囊导管减少了内部弹性损伤,相应减少了内侧骨折长度。此外,C(6)-神经酰胺减少纤维蛋白基质的形成,可能增强随后的伤口愈合反应。我们假设,冠状动脉内皮细胞和平滑肌细胞对外源性神经酰胺的代谢差异可以解释神经酰胺的抗增殖作用和促进伤口愈合反应之间的明显差异。人冠状动脉内皮细胞(HCAEC)与人冠状动脉平滑肌细胞(HCASMC)相比,优先表达神经酰胺激酶,形成神经酰胺-1-磷酸,促进内皮细胞存活。结论:神经酰胺在HCASMC和HCAEC之间的代谢差异提供了神经酰胺优先限制平滑肌细胞生长的机制,在主动伤口愈合的情况下。神经酰胺限制血管平滑肌增殖和促进再内皮化的组合能力,为C(6)-神经酰胺涂层导管作为支架治疗的辅助手段或作为独立治疗提供了潜力。
{"title":"C(6)-Ceramide-Coated Catheters Promote Re-Endothelialization of Stretch-Injured Arteries.","authors":"Sean M O'Neill,&nbsp;Dina K Olympia,&nbsp;Todd E Fox,&nbsp;J Tony Brown,&nbsp;Thomas C Stover,&nbsp;Kristy L Houck,&nbsp;Ronald Wilson,&nbsp;Peter Waybill,&nbsp;Mark Kozak,&nbsp;Steven W Levison,&nbsp;Norbert Weber,&nbsp;Linda M Karavodin,&nbsp;Mark Kester","doi":"10.2174/156727008785133809","DOIUrl":"https://doi.org/10.2174/156727008785133809","url":null,"abstract":"<p><p>OBJECTIVE: Drug eluting stents have recently been associated with the increased risk of adverse thrombogenic events and/or late luminal loss, which is highly associated with incomplete re-endothelialization. The increased risks behoove the design of alternative delivery modalities and/or drugs that do not compromise the re-endotheliaization process. The objective of the present study is to elucidate the biological mechanism(s) by which non-stent-based delivery modalities for the anti-proliferative lipid metabolite, C(6)-ceramide, could lead to a reduction in arterial injury after angioplasty. RESULTS: Immunohistochemical studies in rabbit and porcine models suggest that C(6)-ceramide-coated balloon catheters limit arterial stenosis without inhibiting endothelial wound healing responses. Specifically, C(6)-ceramide-coated balloon catheters reduce internal elastica injury with a corresponding reduction in medial fracture length in a 28-day porcine coronary artery stretch model. In addition, C(6)-ceramide decreases the formation of the fibrin matrix to possibly augment the subsequent wound healing response. We hypothesized that differential metabolism of exogenous ceramide by coronary endothelial and smooth muscle cells could explain the apparent discrepancy between the anti-proliferative actions of ceramide and the pro-wound healing responses of ceramide. Human coronary artery endothelial cells (HCAEC), in contrast to human coronary artery smooth muscle cells (HCASMC), preferentially express ceramide kinase and form ceramide-1-phosphate, which promotes endothelial cell survival. CONCLUSION: Differential metabolism of ceramide between HCASMC and HCAEC offers a mechanism by which ceramide preferentially limits smooth muscle cell growth, in the presence of active wound healing. The combinatorial ability of ceramide to limit vascular smooth muscle proliferation and promote re-endothelialization, offers the potential for C(6)-ceramide-coated catheters to serve as adjuncts to stent-based modalities or as a stand-alone treatment.</p>","PeriodicalId":88793,"journal":{"name":"Vascular disease prevention","volume":"5 3","pages":"200-210"},"PeriodicalIF":0.0,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/156727008785133809","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28535894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Factors Affecting 30-Day Mortality in Chinese Patients with Acute Myocardial Infarction: A Registry-Based Cohort Study 影响中国急性心肌梗死患者30天死亡率的因素:一项基于登记的队列研究
Pub Date : 2008-08-01 DOI: 10.2174/1567270000805010022
I. Yu, W. Chan, Wei Li, C. Yue
{"title":"Factors Affecting 30-Day Mortality in Chinese Patients with Acute Myocardial Infarction: A Registry-Based Cohort Study","authors":"I. Yu, W. Chan, Wei Li, C. Yue","doi":"10.2174/1567270000805010022","DOIUrl":"https://doi.org/10.2174/1567270000805010022","url":null,"abstract":"","PeriodicalId":88793,"journal":{"name":"Vascular disease prevention","volume":"5 1","pages":"174-177"},"PeriodicalIF":0.0,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67887932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vascular disease prevention
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1